[사회]The controversial’AZ Vaccine’ vaccination for the elderly…what is the choice of our pharmaceutical authorities?

[앵커]

The announcement of the results of an expert advisory meeting of the drug authorities on the approval of the AstraZeneca Corona 19 vaccine, which was scheduled for yesterday afternoon, including the availability of vaccination for the elderly, was postponed until today.

This is due to the availability of vaccinations for the elderly, and as more and more European countries say that they will not vaccination to the elderly, the concerns of our pharmaceutical authorities are deepening.

Reporter Choi Jae-min reports.

[기자]

Excluding the 60,000 Pfizer vaccines provided by COVAX, AstraZeneca is the only Corona 19 vaccine confirmed to be introduced in the first quarter of Korea.

630,000 people will be introduced this month, and 1.3 million people assigned by Kovacs will be introduced in the first half.

The quarantine authorities plan to administer this vaccine to medical staff and the elderly first.

[정은경 / 질병관리청장 (지난 1일) : 요양병원·요양시설의 종사자들을 먼저 접종하는 것도 포함해서 검토를 하고 있는 상황입니다.]

However, an increasing number of European countries are questioning the efficacy of the elderly, and the US Food and Drug Administration, the highest authority, has requested additional clinical trials.

Because of this, the concerns of our pharmaceutical authorities are also deepening.

In fact, the Ministry of Food and Drug Safety planned to disclose the use of the AstraZeneca vaccine at the Central Pharmacy Review Committee composed of external experts yesterday.

However, the announcement was postponed for one day due to a heated debate until late at night.

Again, the biggest issue was whether or not to be vaccinated for the elderly.

At the meeting of the verification advisory group on the 31st of last month, the drug authorities were advised to grant a conditional permit.

[김상봉 / 식약처 바이오생약국장(지난 1일) : 참여대상자 중 고령자 수가 적다는 이유만으로 고령자에 대한 투여를 배제할 수 없다는 의견이었습니다.]

Following the announcement of the results of today’s Central Pharmaceutical Affairs Committee meeting, the Ministry of Food and Drug Safety is planning to decide on the approval of the AstraZeneca vaccine item after consulting the final inspection committee soon.

While controversy continues, it is noteworthy whether domestic medical staff and vaccination plans for the elderly who are likely to receive AstraZeneca vaccine intensively in the first and second quarters of this year will be able to navigate.

This is Jaemin Choi from YTN.

※’Your report becomes news’ YTN is waiting for your valuable report.
[카카오톡] Search YTN to add a channel [전화] 02-398-8585 [메일] [email protected] [온라인 제보] www.ytn.co.kr

[저작권자(c) YTN & YTN plus 무단전재 및 재배포 금지]